Compared to other neurodegenerative diseases, ALS seems to have a short preclinical phase, especially in carriers of SOD1 mutations, with serum NfL dynamics similar to that observed in FTD patients. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.